Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients

Bibliography

• NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-4216
   PubMed Web of Science ®Google Scholar
• Filippatos TD, Elisaf MS. High density lipoprotein and cardiovascular diseases. World J Cardiol 2013;5(7):210-14
   PubMedGoogle Scholar
• Mureddu GF, Brandimarte F, De Luca L. High-density lipoprotein levels and risk of cardiovascular events: a review. J Cardiovasc Med (Hagerstown) 2012;13(9):575-86
   PubMed Web of Science ®Google Scholar
• Yu J, Han JL, He LY, et al. Low density lipoprotein cholesterol level inversely correlated with coronary flow velocity reserve in patients with Type 2 diabetes. J Geriatr Cardiol 2013;10(2):159-64
   Google Scholar
• Li L, Ambegaonkar BM, Reckless JP, Jick S. Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus. Eur J Prev Cardiol 2013; doi: 10.1177/2047487313481752
   Google Scholar
• Sampalis JS, Bissonnette S, Boukas S. Effectiveness of ezetimibe in reducing the estimated risk for fatal cardiovascular events in hypercholesterolaemic patients with inadequate lipid control while on statin monotherapy as measured by the SCORE model. Adv Prev Med 2011;2011:597163
   Google Scholar
• Cicero AFG, Ertek S. Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription? Med J Nutr Metab 2008;1(2):85-93
   Google Scholar
• Cicero AF, Ferroni A, Ertek S. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin Drug Saf 2012;11(5):753-66
   PubMed Web of Science ®Google Scholar
• Derosa G, Cicero AFG, Fogari E, et al. Effects of n-3 PUFAs on insulin resistance after an oral fat load. Eur J Lipid Sci Technol 2011;113(8):950-60
   Web of Science ®Google Scholar
• Derosa G, Cicero AFG, Fogari E, et al. n-3 PUFAs effects on post-prandial variation of metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. J Clin Lipidol 2012;6(6):553-64
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 2012;12(8):1113-24
   PubMed Web of Science ®Google Scholar
• Derosa G, D'Angelo A, Bonaventura A, et al. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opin Biol Ther 2013;13(4):475-82
   PubMed Web of Science ®Google Scholar
• Potdar D, Hirwani RR, Dhulap S. Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 2012;83(5):817-30
   PubMed Web of Science ®Google Scholar
• Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10(12):1344-51
   PubMed Web of Science ®Google Scholar
• Hu Y, Davies GE. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia 2010;81(5):358-66
   PubMed Web of Science ®Google Scholar
• Chen W, Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech 2011;12(2):705-11
   PubMed Web of Science ®Google Scholar
• Pan GY, Wang GJ, Liu XD, et al. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 2002;91(4):193-7
   PubMedGoogle Scholar
• Chae HW, Kim IW, Jin HE, et al. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine. Arch Pharm Res 2008;31(1):103-10
   PubMed Web of Science ®Google Scholar
• Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev 1998;3(6):410-21
   PubMedGoogle Scholar
• Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36(1):57-104
   PubMed Web of Science ®Google Scholar
• Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev 2005;10(3):193-203
   PubMed Web of Science ®Google Scholar
• Di Pierro F, Villanova N, Agostini F, et al. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab Syndr Obes 2012;5:213-17
   PubMedGoogle Scholar
• The Council for International Organisation of Medical Sciences. Proposed international guidelines for biomedical research involving human subjects. Geneva: 1982
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. Report of WHO consultation on obesity. WHO; Geneva: 1997
   Google Scholar
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-83
   PubMed Web of Science ®Google Scholar
• A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999;16:716-30
   PubMed Web of Science ®Google Scholar
• Klose S, Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem [Enzymatic dosage of total cholesterolemia by Greiner Selective Analyzer (GSA II)]. J Clin Chem Clin Biochem 1978;15:121-30
   Google Scholar
• Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 2nd English edition. Academic Press; New York, USA: 1974. p. 18-31
   Google Scholar
• Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
   PubMed Web of Science ®Google Scholar
• El Kenz H, Bergmann P. Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur. Clin Lab 2004;50:171-4
   PubMedGoogle Scholar
• Miki H, Matsuyama T, Fujii S, et al. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes. Diabetes Res Clin Pract 1992;18(2):99-105
   PubMed Web of Science ®Google Scholar
• Winer BJ. Statistical principles in experimental design. 2nd edition. McGraw-Hill; New York, USA: 1971
   Google Scholar
• Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med 2013;79(06):437-46
   PubMedGoogle Scholar
• Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 2006;47(6):1281-8
   PubMed Web of Science ®Google Scholar
• Skottová N, Vecera R, Urbánek K, et al. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacol Res 2003;47(1):17-26
   PubMed Web of Science ®Google Scholar
• Sobolová L, Skottová N, Vecera R, Urbánek K. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacol Res 2006;53(2):104-12
   PubMed Web of Science ®Google Scholar
• Wang ZS, Lu FE, Chen G, et al. Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells. Yao Xue Xue Bao 2007;42(10):1045-9
   PubMedGoogle Scholar
• Cheng Z, Pang T, Gu M, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta 2006;1760(11):1682-9
   PubMed Web of Science ®Google Scholar
• Huseini HF, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006;20(12):1036-9
   PubMed Web of Science ®Google Scholar